N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin.
N-Boc-Phe-Leu-Phe-Leu-Phe is a synthetic peptide composed of alternating phenylalanine (Phe) and leucine (Leu) residues, capped at the N-terminus with a tert-butyloxycarbonyl (Boc) protecting group. As a custom-designed peptide, it serves as a valuable molecular tool in a wide range of biochemical and biophysical investigations. Its defined sequence and hydrophobic character make it particularly relevant for studies involving peptide structure, protein-protein interactions, and the development of peptide-based materials. The Boc-protected N-terminus enhances its stability during synthesis and handling, supporting its use in advanced peptide research and functional assays.
Peptide structure-function analysis: N-Boc-Phe-Leu-Phe-Leu-Phe is frequently utilized in research focused on understanding the structural determinants of peptide folding and aggregation. The alternating hydrophobic residues facilitate the formation of specific secondary structures, such as beta-sheets or helical motifs, which are critical for elucidating the relationship between primary sequence and higher-order conformation. Researchers employ this peptide as a model system to investigate how sequence composition influences peptide self-assembly, stability, and intermolecular interactions, providing insights relevant to both natural and engineered protein systems.
Protease substrate studies: Due to its defined sequence and the presence of both phenylalanine and leucine residues, this peptide is suitable as a substrate in enzymatic assays designed to characterize protease specificity and activity. The N-terminal Boc group offers protection during assay setup, allowing for controlled exposure of the peptide to a range of proteolytic enzymes. Such studies are essential for mapping cleavage sites, evaluating enzyme kinetics, and screening for protease inhibitors in pharmaceutical and biochemical research.
Solid-phase peptide synthesis (SPPS) optimization: The Boc-protected pentapeptide serves as a practical intermediate or model compound in the optimization and validation of solid-phase peptide synthesis protocols. Its sequence complexity and hydrophobicity challenge both resin selection and coupling efficiency, making it an ideal candidate for testing new synthetic strategies or evaluating the performance of coupling reagents. By monitoring yields and purity, chemists can refine SPPS conditions for more complex peptide targets.
Peptide-membrane interaction assays: The amphipathic nature of alternating phenylalanine and leucine residues enables this peptide to interact with model lipid bilayers, making it useful in studies of peptide-membrane association and permeabilization. Such assays provide mechanistic insight into how hydrophobic peptides partition into or disrupt biological membranes, which is fundamental for the design of antimicrobial peptides, drug delivery vectors, and membrane-active biomaterials.
Analytical method development: N-Boc-Phe-Leu-Phe-Leu-Phe is also employed as a reference standard or calibration compound in the development and validation of analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Its defined mass, sequence, and physicochemical properties make it suitable for assessing method sensitivity, resolution, and reproducibility in peptide analysis workflows. This facilitates accurate quantification and quality control in peptide research and production environments.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More